Literature DB >> 17301065

Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk.

Bernd Frank1, Justo Lorenzo Bermejo, Kari Hemminki, Christian Sutter, Barbara Wappenschmidt, Alfons Meindl, Marion Kiechle-Bahat, Peter Bugert, Rita K Schmutzler, Claus R Bartram, Barbara Burwinkel.   

Abstract

Copy number variants (CNVs), insertions, deletions and duplications, contribute considerably to human genetic variation and disease development. A recent study has characterized 100 CNVs including a deletion in the mitochondrial tumor suppressor gene 1 (MTUS1) lacking the coding exon 4. MTUS1 maps to chromosome 8p, a region frequently deleted and associated with disease progression in human cancers, including breast cancer (BC). To investigate the effect of the MTUS1 CNV on familial BC risk, we analyzed 593 BC patients and 732 control individuals using a case-control study design. We found a significant association of the deletion variant with a decreased risk for both familial and high-risk familial BC (odds ratio (OR) = 0.58, 95% confidence interval (CI) = 0.37-0.90, P = 0.01 and OR = 0.41, 95% CI = 0.23-0.74, P = 0.003), supporting its role in human cancer. To our knowledge, the present study is the first to determine the impact of a CNV in a tumor suppressor gene on cancer risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301065     DOI: 10.1093/carcin/bgm033

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  32 in total

Review 1.  The current excitement about copy-number variation: how it relates to gene duplications and protein families.

Authors:  Jan O Korbel; Philip M Kim; Xueying Chen; Alexander Eckehart Urban; Sherman Weissman; Michael Snyder; Mark B Gerstein
Journal:  Curr Opin Struct Biol       Date:  2008-05-27       Impact factor: 6.809

2.  Population-genetic properties of differentiated human copy-number polymorphisms.

Authors:  Catarina D Campbell; Nick Sampas; Anya Tsalenko; Peter H Sudmant; Jeffrey M Kidd; Maika Malig; Tiffany H Vu; Laura Vives; Peter Tsang; Laurakay Bruhn; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2011-03-11       Impact factor: 11.025

3.  Reduced expression of MTUS1 mRNA is correlated with poor prognosis in bladder cancer.

Authors:  Jun Xiao; Jun-Xing Chen; Yu-Ping Zhu; Lin-Yu Zhou; Qi-An Shu; Ling-Wu Chen
Journal:  Oncol Lett       Date:  2012-04-05       Impact factor: 2.967

4.  Identification of differently expressed genes with specific SNP Loci for breast cancer by the integration of SNP and gene expression profiling analyses.

Authors:  Pengfei Yuan; Dechun Liu; Miao Deng; Jiangbo Liu; Jianguang Wang; Like Zhang; Qipeng Liu; Ting Zhang; Yanbin Chen; Gaoyuan Jin
Journal:  Pathol Oncol Res       Date:  2014-11-19       Impact factor: 3.201

5.  8p deletion is strongly linked to poor prognosis in breast cancer.

Authors:  P Lebok; A Mittenzwei; M Kluth; C Özden; B Taskin; K Hussein; K Möller; A Hartmann; A Lebeau; I Witzel; S Mahner; L Wölber; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; R Simon; G Sauter; L Terracciano; R Krech; A von der Assen; V Müller; E Burandt
Journal:  Cancer Biol Ther       Date:  2015-05-11       Impact factor: 4.742

Review 6.  The role of the basal stem cell of the human breast in normal development and cancer.

Authors:  Jose Russo; Irma H Russo
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

7.  Copy number variations and cancer.

Authors:  Adam Shlien; David Malkin
Journal:  Genome Med       Date:  2009-06-16       Impact factor: 11.117

8.  8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis.

Authors:  Sylvie Rodrigues-Ferreira; Anne Di Tommaso; Ariane Dimitrov; Sylvie Cazaubon; Nadège Gruel; Hélène Colasson; André Nicolas; Nathalie Chaverot; Vincent Molinié; Fabien Reyal; Brigitte Sigal-Zafrani; Benoit Terris; Olivier Delattre; François Radvanyi; Franck Perez; Anne Vincent-Salomon; Clara Nahmias
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

9.  Disorders of the genome architecture: a review.

Authors:  Dhavendra Kumar
Journal:  Genomic Med       Date:  2009-03-11

10.  MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.

Authors:  Onder Ozcan; Murat Kara; Onder Yumrutas; Esra Bozgeyik; Ibrahim Bozgeyik; Ozgur Ilhan Celik
Journal:  Tumour Biol       Date:  2015-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.